IONIS PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Ionis Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$149M, a 3.76% decline year-over-year.
  • Ionis Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$370M, a 33.3% increase year-over-year.
  • Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$354M, a 13.8% increase from 2022.
  • Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$410M, a 1259% decline from 2021.
  • Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$30.2M, a 82.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$370M -$149M -$5.39M -3.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$365M -$66.1M +$24.1M +26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$389M -$150M -$35.4M -31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$354M -$6.12M +$202M +97.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$556M -$143M -$84.1M -142% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$472M -$90.2M -$4.68M -5.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$467M -$114M -$56.6M -98.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$410M -$208M -$429M -194% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $18.4M -$59.2M +$26.7M +31.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$8.26M -$85.5M -$12.5M -17.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.28M -$57.5M +$34.5M +37.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$30.2M $221M +$243M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-22
Q3 2021 -$273M -$85.8M -$49.3M -135% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$224M -$73M -$21.2M -41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$203M -$92M -$30.8M -50.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$172M -$22.7M -$283M -109% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $111M -$36.5M -$39.1M -1548% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $150M -$51.8M -$32.9M -175% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $183M -$61.1M -$183M -150% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $366M $261M +$250M +2317% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $116M $2.52M +$21.1M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $94.9M -$18.8M +$31.5M +62.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $63.5M $122M +$125M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$61.4M $10.8M +$17M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$78.4M -$18.6M -$29.9M -264% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$48.5M -$50.3M -$56.7M -880% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $8.26M -$3.3M -$22.8M -117% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $31M -$6.2M -$47.4M -115% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $78.4M $11.3M -$4.8M -29.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $83.2M $6.45M +$55.4M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 $27.8M $19.5M +$74.1M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$46.3M $41.2M +$104M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 -$150M $16.1M +$64.2M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 -$215M -$48.9M -$93.6M -210% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 -$121M -$54.7M -$45.3M -486% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 -$75.8M -$62.9M -$73M -724% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$2.74M -$48.1M -$26.6M -124% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $23.9M $44.6M +$51.3M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$27.4M -$9.33M +$20.3M +68.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$47.7M $10.1M +$29.9M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$77.7M -$21.5M +$4.01M +15.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$81.7M -$6.65M +$1.28M +16.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$83M -$29.7M -$31.3M -1926% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 -$51.7M -$19.9M +$6.26M +24% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$57.9M -$25.5M +$2.54M +9.06% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$60.5M -$7.93M -$11.6M -315% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$48.8M $1.63M +$20.1M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 -$68.9M -$26.1M -$7.5M -40.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 -$61.4M -$28M -$5.73M -25.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-03
Q2 2012 -$55.7M $3.7M +$17.8M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-03
Q1 2012 -$73.4M -$18.5M -$2.35M -14.6% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-03
Q4 2011 -$71.1M -$18.6M -$2.76M -17.4% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 -$68.3M -$22.3M -$13.4M -149% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-28
Q2 2011 -$55M -$14.1M +$4.61M +24.7% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-28
Q1 2011 -$59.6M -$16.1M -$11.2M -230% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-28
Q4 2010 -$48.4M -$15.9M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 -$8.95M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 -$18.7M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 -$4.88M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.